Clinical Trial Update: Open Label Study of TRx0014 in Alzheimer's Disease [Phase 2]

View source ↗

Summary

Open-label Phase 2 trial of TRx0014 in Alzheimer's disease has completed. No efficacy data are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• TRx0014

Snippet

Sponsor: TauRx Therapeutics Ltd | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED